Xencor Reports First Quarter 2024 Financial Results Read more about Xencor Reports First Quarter 2024 Financial Results
Xencor Appoints Bart Cornelissen as Chief Financial Officer Read more about Xencor Appoints Bart Cornelissen as Chief Financial Officer
Xencor to Present at Upcoming Investor Conferences Read more about Xencor to Present at Upcoming Investor Conferences
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results Read more about Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update Read more about Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update
Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference Read more about Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy Read more about Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy
Xencor to Present at the Piper Sandler 35th Annual Healthcare Conference Read more about Xencor to Present at the Piper Sandler 35th Annual Healthcare Conference
Xencor Reports Third Quarter 2023 Financial Results Read more about Xencor Reports Third Quarter 2023 Financial Results
Xencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 Million Read more about Xencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 Million